Aranzazu Chamorro-Jorganes

Aranzazu Chamorro-Jorganes

Auto-generated profile, based on publicly available information

Aranzazu Chamorro-Jorganes

Imperial College London, National Heart and Lung Institute , London , United Kingdom

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2011 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
PDF file
ACAránzazu Chamorro-Jorganes
Aránzazu Chamorro-Jorganes
EAElisa Araldi
Elisa Araldi
Luiz PenalvaLuiz Penalva
Luiz Penalva
DSDevraj Sandhu
Devraj Sandhu
CFCarlos Fernández-Hernando
Carlos Fernández-Hernando
YSYajaira Suárez
Yajaira Suárez
Objective—: MicroRNAs play key roles in modulating a variety of cellular processes by posttranscriptional regulation of their target genes. Vascular endothelial growth factor (VEGF), VEGF receptor-2 (VEGFR2), and fibroblast growth factor receptor-1 (FGFR1) were identified by bioinformatic approaches and subsequently validated as targets of microRNA (miR)-16 and miR-424 in endothelial cells (ECs). Methods and Results—: Mimetics of these microRNAs reduced VEGF, VEGFR2, and FGFR1 expression, whereas specific antagonists enhanced their expression. Expression of mature miR-16 and miR-424 was upregulated on VEGF or basic fibroblast growth factor (bFGF) treatment. This upregulation was accompanied by a parallel increase in primary transcript (pri-miR)-16-1 and pri-miR-16-2 but not in pri-miR-424 levels, indicating a VEGF/bFGF-dependent transcriptional and posttranscriptional regulation of miR-16 and miR-424, respectively. Reduced expression of VEGFR2 and FGFR1 by miR-16 or miR-424 overexpression regulated VEGF and bFGF signaling through these receptors, thereby affecting the activity of downstream components of the pathways. Functionally, miR-16 or miR-424 overexpression reduced proliferation, migration, and cord formation of ECs in vitro, and lentiviral overexpression of miR-16 reduced the ability of ECs to form blood vessels in vivo. Conclusion—: We conclude that these miRNAs fine-tune the expression of selected endothelial angiogenic mediators in response to these growth factors. Altogether, these findings suggest that miR-16 and miR-424 play important roles in regulating cell-intrinsic angiogenic activity of ECs.

8 January 2016 in Circulation Research
Verified
Journal Article
Open access
PDF file
ACAránzazu Chamorro-Jorganes
Aránzazu Chamorro-Jorganes
MLMonica Y. Lee
Monica Y. Lee
EAElisa Araldi
Elisa Araldi
SLShira Landskroner-Eiger
Shira Landskroner-Eiger
MFMarta Fernández-Fuertes
Marta Fernández-Fuertes
YSYajaira Suárez
Yajaira Suárez
Rationale:: Several lines of evidence indicate that the regulation of microRNA (miRNA) levels by different stimuli may contribute to the modulation of stimulus-induced responses. The miR-17–92 cluster has been linked to tumor development and angiogenesis, but its role in vascular endothelial growth factor–induced endothelial cell (EC) functions is unclear and its regulation is unknown. Objective:: The purpose of this study was to elucidate the mechanism by which VEGF regulates the expression of miR-17–92 cluster in ECs and determine its contribution to the regulation of endothelial angiogenic functions, both in vitro and in vivo. This was done by analyzing the effect of postnatal inactivation of miR-17–92 cluster in the endothelium (miR-17–92 iEC-KO mice) on developmental retinal angiogenesis, VEGF-induced ear angiogenesis, and tumor angiogenesis. Methods and Results:: Here, we show that Erk/Elk1 activation on VEGF stimulation of ECs is responsible for Elk-1-mediated transcription activation (chromatin immunoprecipitation analysis) of the miR-17–92 cluster. Furthermore, we demonstrate that VEGF-mediated upregulation of the miR-17–92 cluster in vitro is necessary for EC proliferation and angiogenic sprouting. Finally, we provide genetic evidence that miR-17–92 iEC-KO mice have blunted physiological retinal angiogenesis during development and diminished VEGF-induced ear angiogenesis and tumor angiogenesis. Computational analysis and rescue experiments show that PTEN (phosphatase and tensin homolog) is a target of the miR-17–92 cluster and is a crucial mediator of miR-17-92–induced EC proliferation. However, the angiogenic transcriptional program is reduced when miR-17–92 is inhibited. Conclusions:: Taken together, our results indicate that VEGF-induced miR-17–92 cluster expression contributes to the angiogenic switch of ECs and participates in the regulation of angiogenesis.

1 March 2012 in Cell Cycle
Verified
Journal Article
Closed access
DCDaniel Cirera-Salinas
Daniel Cirera-Salinas
MPMontse Pauta
Montse Pauta
RARyan M. Allen
Ryan M. Allen
Alessandro SalernoAlessandro Salerno
Alessandro Salerno
Cristina M. Ramírez HidalgoCristina M. Ramírez Hidalgo
Cristina M. Ramírez Hidalgo
CFCarlos Fernández-Hernando
Carlos Fernández-Hernando
Cholesterol metabolism is tightly regulated at the cellular level and is essential for cellular growth. microRNAs (miRNAs), a class of noncoding RNAs, have emerged as critical regulators of gene ex...

1 June 2013 in Molecular and Cellular Biology
Verified
Journal Article
Open access
PDF file
LGLeigh Goedeke
Leigh Goedeke
FVFrances M. Vales-Lara
Frances M. Vales-Lara
MFMichael Fenstermaker
Michael Fenstermaker
DCDaniel Cirera-Salinas
Daniel Cirera-Salinas
ACAranzazu Chamorro-Jorganes
Aranzazu Chamorro-Jorganes
CFCarlos Fernández-Hernando
Carlos Fernández-Hernando
Hsa-miR-33a and hsa-miR-33b, intronic microRNAs (miRNAs) located within the sterol regulatory element-binding protein 2 and 1 genes (Srebp-2 and -1), respectively, have recently been shown to regulate lipid homeostasis in concert with their host genes. Although the functional role of miR-33a and -b has been highly investigated, the role of their passenger strands, miR-33a* and -b*, remains unclear. Here, we demonstrate that miR-33a* and -b* accumulate to steady-state levels in human, mouse, and nonhuman primate tissues and share a similar lipid metabolism target gene network as their sister strands. Analogous to miR-33, miR-33* represses key enzymes involved in cholesterol efflux (ABCA1 and NPC1), fatty acid metabolism (CROT and CPT1a), and insulin signaling (IRS2). Moreover, miR-33* also targets key transcriptional regulators of lipid metabolism, including SRC1, SRC3, NFYC, and RIP140. Importantly, inhibition of either miR-33 or miR-33* rescues target gene expression in cells overexpressing pre-miR-33. Consistent with this, overexpression of miR-33* reduces fatty acid oxidation in human hepatic cells. Altogether, these data support a regulatory role for the miRNA* species and suggest that miR-33 regulates lipid metabolism through both arms of the miR-33/miR-33* duplex.

27 December 2012 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
LDLaura S. Danielson
Laura S. Danielson
DPDavid S. Park
David S. Park
NVNoemi Rotllan Vila
Noemi Rotllan Vila
ACAranzazu Chamorro‐Jorganes
Aranzazu Chamorro‐Jorganes
MGMaria V. Guijarro
Maria V. Guijarro
EHEva Hernando
Eva Hernando
MicroRNA cluster miR‐17‐92 has been implicated in cardiovascular development and function, yet its precise mechanisms of action in these contexts are uncertain. This study aimed to investigate the role of miR‐17‐92 in morphogenesis and function of cardiac and smooth muscle tissues. To do so, a mouse model of conditional overexpression of miR‐17‐92 in cardiac and smooth muscle tissues was generated. Extensive cardiac functional studies identified a dose‐dependent induction of dilated, hypertrophic cardiomyopathy, and arrhythmia inducibility in transgenic animals, which correlated with premature mortality (98.3±42.5 d, P <0.0001). Expression analyses revealed the abundance of Pten transcript, a known miR‐17‐92 target, to be inversely correlated with miR‐17‐92 expression levels and heart size. In addition, we demonstrated through 3′‐UTR luciferase assays and expression analyses that Connexin43 (Cx43) is a novel direct target of miR‐19a/b and its expression is suppressed in transgenic hearts. Taken together, these data demonstrate that dysregulated expression of miR‐17‐92 during cardiovascular morphogenesis results in a lethal cardiomyopathy, possibly in part through direct repression of Pten and Cx43. This study highlights the importance of miR‐17‐92 in both normal and pathological functions of the heart, and provides a model that may serve as a useful platform to test novel antiarrhythmic therapeutics.—Danielson, L. S., Park, D. S., Rotllan, N., Chamorro‐Jorganes, A., Guijarro, M. V., Fernandez‐Hernando, C., Fishman, G. I., Phoon, C. K. L., Hernando, E. Cardiovascular dysregulation of miR‐17‐92 causes a lethal hypertrophic cardiomyopathy and arrhythmogenesis. FASEB J. 27, 1460–1467 (2013). www.fasebj.org

1 September 2013 in Pharmacological Research
Verified
Journal Article
Open access
ACAránzazu Chamorro-Jorganes
Aránzazu Chamorro-Jorganes
EAElisa Araldi
Elisa Araldi
YSYajaira Suárez
Yajaira Suárez
Endothelial cell dysfunction is a term which implies the dysregulation of normal endothelial cell functions, including impairment of the barrier functions, control of vascular tone, disturbance of proliferative, migratory and morphogenic capacities of endothelial cells, as well as control of leukocyte trafficking. MicroRNAs are short non-coding RNAs that have emerged as critical regulators of gene expression acting predominantly at the post-transcriptional level. This review summarizes the latest insights in the identification of endothelial-specific microRNAs and their targets, as well as their roles in controlling endothelial cell functions in both autocrine and paracrine manner. In addition, we discuss the therapeutic potential for the treatment of endothelial cell dysfunction and associated vascular pathophysiological conditions.